TY  - JOUR
A1  - Bourdeaux, Florian Alexander
A1  - Rittner, Alexander
A1  - Grininger, Martin
T1  - Impfstoffe für alle? Dodecin als Impfstoffplattform
T2  - Biospektrum
N2  - The Corona pandemic has painfully taught us the threat of new pathogens in a globalized world and how vital modern vaccines are. Platform technologies play an important role in the discovery of new vaccines as reducing the time for the development dramatically — time that saves lives. Here, we present the protein Dodecin and how it may be utilized as a versatile platform technology to produce cheap and robust new vaccines for everyone in all parts of the world.
Y1  - 2021
UR  - http://publikationen.ub.uni-frankfurt.de/frontdoor/index/index/docId/79941
UR  - https://nbn-resolving.org/urn:nbn:de:hebis:30:3-799419
SN  - 1868-6249
N1  - Das Projekt und die Weiterentwicklung der Dodecin plattformtechnologie wird von den Goethe-Corona-Fonds (an M.G.) und dem GO-Bio initial Programm des BMBFs (an F.B. und A.R.) gefördert.
Open Access funding enabled and organized by Projekt DEAL.
VL  - 27
IS  - 3
SP  - 250
EP  - 253
PB  - Spektrum
CY  - Heidelberg
ER  -